Pluristyx Inc.
Seattle, WA
- UEI
- UVKAQJ9AL796
- CAGE
- 848D2
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
-
- 325411 Medicinal and Botanical Manufacturing
- 325412 Pharmaceutical Preparation Manufacturing
- 325413 In-Vitro Diagnostic Substance Manufacturing
- 541690 Other Scientific and Technical Consulting Services
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- 541990 All Other Professional, Scientific, and Technical Services
- 621511 Medical Laboratories
- SAM.gov registration date
- Physical address
- Waterfront Research Center, 201 Elliott Ave W Suite 290, Seattle, WA 98119, USA
- Website
- pluristyx.com
- Founded
- 2018
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 80 Health Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Not on record | W911NF1730003 | $100,000 |
Similar vendors
About the company
Pluristyx Inc. is a for-profit corporation registered to receive federal grant awards. The company specializes in advanced cellular technologies, particularly in the areas of cell differentiation monitoring and bioreactor systems for cell expansion. As a manufacturer of goods, Pluristyx Inc. appears to focus on developing innovative solutions for cellular research and biotechnology applications. The company's expertise in these fields suggests that it plays a significant role in advancing scientific research and potentially contributing to medical breakthroughs through its products and services.
Based on the federal grant sub-awards received, Pluristyx Inc. has been involved in two main projects. The first project involves the development of a Cell Differentiation Monitoring System, which likely allows researchers to track and analyze the process of cell differentiation in real-time. The second project focuses on an Integrated Bioreactor-Settler for Ex Vivo Cell Expansion and Harvest, which is presumably designed to efficiently grow and collect cells outside of their natural environment. These projects indicate that Pluristyx Inc. is at the forefront of creating sophisticated tools for cellular research and biotechnology applications. While specific funding agencies are not mentioned, the grant IDs suggest potential involvement with military or defense-related research, as evidenced by the "W911NF" prefix in some of the award IDs. The company's ability to secure multiple sub-awards for these projects demonstrates its expertise and reliability in delivering specialized cellular technology solutions to support federally funded research initiatives.
Quick answers
Is Pluristyx Inc. registered in SAM.gov?
Yes. Pluristyx Inc.'s SAM.gov registration is active through June 18, 2027.
On GovTribe
See Pluristyx Inc.'s full federal record
- Similar vendors